GE

232.05

+1.15%↑

RTX

135.42

+0.42%↑

CAT

353.58

+0.97%↑

BA

205.59

-0.15%↓

HON

222.68

+0.17%↑

GE

232.05

+1.15%↑

RTX

135.42

+0.42%↑

CAT

353.58

+0.97%↑

BA

205.59

-0.15%↓

HON

222.68

+0.17%↑

GE

232.05

+1.15%↑

RTX

135.42

+0.42%↑

CAT

353.58

+0.97%↑

BA

205.59

-0.15%↓

HON

222.68

+0.17%↑

GE

232.05

+1.15%↑

RTX

135.42

+0.42%↑

CAT

353.58

+0.97%↑

BA

205.59

-0.15%↓

HON

222.68

+0.17%↑

GE

232.05

+1.15%↑

RTX

135.42

+0.42%↑

CAT

353.58

+0.97%↑

BA

205.59

-0.15%↓

HON

222.68

+0.17%↑

Search

Enovis Corp

Aperta

SettoreTop Industriali

36.09 0.56

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

35.03

Massimo

36.14

Metriche Chiave

By Trading Economics

Entrata

647M

-56M

Vendite

-2.1M

559M

EPS

0.81

Margine di Profitto

-9.968

Dipendenti

7,367

EBITDA

535M

-56M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+57.76% upside

Dividendi

By Dow Jones

Utili prossimi

6 ago 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-372M

2.1B

Apertura precedente

35.53

Chiusura precedente

36.09

Notizie sul Sentiment di mercato

By Acuity

41%

59%

165 / 466 Classifica in Industrials

Enovis Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

7 gen 2025, 23:28 UTC

I principali Market Mover

Maplebear Up on S&P MidCap 400 Inclusion

Confronto tra pari

Modifica del prezzo

Enovis Corp Previsione

Obiettivo di Prezzo

By TipRanks

57.76% in crescita

Previsioni per 12 mesi

Media 57.14 USD  57.76%

Alto 75 USD

Basso 37 USD

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Enovis Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

8 ratings

7

Acquista

1

Mantieni

0

Vendi

Sentiment

By Acuity

165 / 466 Classifica in Top Industriali

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Enovis Corp

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.